Retinitis pigmentosa (RP) is a term for a group of ... Most people with RP lose much of their sight by early adulthood. Then by age 40, they are often legally blind. But RP only rarely causes ...

OCU400 is Ocugen’s novel modifier gene therapy for retinitis pigmentosa (RP). The OCU400 (AAV5-h NR2E3) gene therapy platform ...

A breakthrough treatment has allowed damaged retinal cells to regenerate themselves. The current research has been conducted ...

A team of UC Davis Health researchers has shown that CD34 + stem cells can be safely administered into retinitis pigmentosa ...

Vision loss due to retinitis pigmentosa is typically irreversible. However, infectious retinitis can improve if doctors catch it early and treat it appropriately. Retinitis is often a progressive ...

Retinitis pigmentosa (RP) is a group of genetic eye ... Others go completely blind from RP, in some cases as early as childhood. Progression of RP is different in each case. RP is a type of ...

Retinitis pigmentosa (RP) involves inherited retinal ... and availability of advanced diagnostic tools are promoting early diagnosis and treatment, further boosting market expansion.

Retinitis pigmentosa is a rare visual disorder that ... their rods are usually affected first, which is why an early sign of the disease is struggling to see at night. Another sign is bumping ...

The expanded access program (EAP) will allow patients aged 18 years and older with early and intermediate to advanced retinitis pigmentosa (RP) with at least minimal retinal preservation to be ...

Beacon Therapeutics may have found a guiding light in a disease area where other companies have stumbled with its laruparetigene zovaparvovec (laru-zova), a gene therapy that proved early improveme ...